Enanta Pharmaceuticals Announces AbbVie’s Investigational Regimen of Glecaprevir/Pibrentasvir Shows High SVR Rates
Coelacanth Energy Inc. Announces Operations Update, Revised Reserve Report and Initial Resource Report